News

Type-1 Diabetes Mellitus (T1DM)is a disease in which the islet cells of the pancreas fail to produce the essential hormone, insulin. Currently, the standard therapy for T1DM in companion animals ...
Virbac Animal Health acquired worldwide rights to develop NovaBay Pharmaceutical’s compound auriclosene (NVC-422) for global veterinary markets by exercising an option under a year-old agreement ...
At the helm of Westlake-based animal health company Virbac North America, Giovanni Abruzzini will seek to gain market share and visibility in the North American market through additional market ...
French drugmaker Virbac said Monday it would pick up two products marketed by Novartis Animal Health in the U.S.--the parasiticides Sentinel Flavor Tabs and Sentinel Spectrum--which Eli Lilly has ...
Little more than a month after launching a pivotal trial for its lead compound to treat osteoarthritis in dogs, Dublin-based Nexvet has nabbed a partner to help distribute it--Virbac, which signed ...